SESSION INTENT

SUMMARY

• User requested: “Principle of management of hypoparathyroidism — Ppt of 5-6 slides with appropriate images.”
• Required skills were invoked:
  • Medical-library skill for authoritative clinical information.
  • PPTX skill for presentation creation.
• No existing template or reference deck was supplied; create a new 16:9 deck using python-pptx.

Clinical content gathered for the deck

• Chronic hypoparathyroidism conventional management consists of:
  • Adequate dietary calcium, with or without oral calcium supplements.
  • Activated vitamin D (e.g., calcitriol).
• Textbook snippet supports:
  • Calcitriol: approximately 0.2–1 μg/day.
  • Elemental calcium supplementation: 2–3 g/day (note: guideline dosing should be individualized; avoid framing as a universal fixed dose).
  • Magnesium supplementation when appropriate.
  • Endocrinology/nephrology involvement for complex cases.

• Relieve symptoms/signs of hypocalcemia while avoiding overtreatment.
• Maintain serum calcium in the low-normal or just-below-normal range rather than fully normal/high-normal.
• Avoid hypercalciuria, nephrolithiasis/nephrocalcinosis, renal impairment, hyperphosphatemia, and elevated calcium–phosphate product.
• Optimize magnesium and maintain adequate nutritional vitamin D (25-OH D).

• Emergency clinical principle: severe/symptomatic hypocalcemia (e.g., tetany, seizures, laryngospasm, arrhythmia/QT prolongation) requires IV calcium gluconate, cardiac/ECG monitoring, correction of magnesium deficiency, and transition to oral calcium plus calcitriol once stabilized.
• This should be shown as an escalation/acute-care pathway and clearly differentiated from chronic therapy.

• Monitor serum calcium (ionized or albumin-adjusted), phosphate, magnesium, creatinine/eGFR, and 25-OH vitamin D.
• Measure urinary calcium (typically 24-hour urinary calcium) to detect hypercalciuria.
• Consider renal imaging when indicated for stones/nephrocalcinosis.
• Monitor more frequently after changes in calcium, calcitriol, diuretics, or PTH therapy; stable patients can be checked periodically.
• Thiazide plus low-sodium diet can reduce hypercalciuria when needed, with electrolyte/BP monitoring.

• PTH replacement is an adjunct/second-line approach for patients inadequately controlled on optimized conventional therapy, particularly with persistent symptomatic hypocalcemia, hypercalciuria/renal complications, hyperphosphatemia, poor quality of life, malabsorption, or inability to tolerate/high requirements of calcium and active vitamin D.
• 2025 ESE guideline search result: PTH replacement can reduce pill burden, improve biochemical measures, and may improve quality of life.
• Do not overstate availability or name a specific product without checking regional approval/access. Present as “consider PTH replacement in selected, inadequately controlled patients under endocrinology supervision.”

Sources/evidence located

• 2025 European Journal of Endocrinology guideline:
  • Bollerslev J et al. “Treatment of Chronic Hypoparathyroidism in Adults.”
  • Search result URL: https://academic.oup.com/ejendo/article-pdf/193/5/G49/65274063/lvaf222.pdf
  • Search result confirms conventional treatment uses dietary/supplemental calcium plus activated vitamin D.
  • Another result URL: https://academic.oup.com/ejendo/article/193/5/G83/8321487
  • Web extraction failed for both URLs, but search snippets are usable as source pointers.
• 2022 Second International Workshop guideline was identified in textbook references:
  • Khan AA et al. Evaluation and management of hypoparathyroidism: summary statement and guidelines from the Second International Workshop. J Bone Miner Res. 2022;37:2568–2585.
• Earlier management review:
  • Bilezikian JP et al. Management of Hypoparathyroidism: Present and Future. JCEM. 2016;101(6):2313–2324.
• Textbook:
  • Fitzpatrick’s Dermatology, management section: /textbooks/9780071837781/9780071837781_block21.md, lines 5174–5184. Contains calcitriol 0.2–1 μg/day, calcium 2–3 g elemental calcium, magnesium when appropriate, endocrine/nephrology consultation.
• Recent evidence found:
  • 2024 systematic review: quality of life in patients receiving standard treatment, PMID 38578400.
  • 2024 meta-analysis of post-thyroidectomy hypoparathyroidism management, PMID 38013484.
  • 2026 pediatric teriparatide systematic review/meta-analysis, PMID 42501079 (not essential for a general adult deck).

Visual resources

• External image search for “hypoparathyroidism management calcium vitamin D diagram chronic treatment” returned no results.
• A generated educational infographic is available:
  • https://cdn.orris.care/image-gen/9a116f04e74345938543ef04df298543.png
  • Prompt used: educational medical illustration showing low PTH → low calcium, calcium supplements and active vitamin D, clean labelled clinical infographic.
• Use this image in the deck if accessible/downloadable. Additional visuals can be built natively with PowerPoint shapes (treatment pathway, monitoring icons, decision flow) to ensure relevant images rather than relying on web search.

Recommended 6-slide structure

1. Title slide — “Principles of Management of Hypoparathyroidism”
   • Subtitle: acute stabilization, long-term control, and complication prevention.
   • Use generated infographic or a clean calcium/PTH visual.
2. Management goals & initial assessment
   • Symptom control; low-normal calcium target; avoid renal/soft-tissue complications.
   • Baseline tests: calcium, phosphate, magnesium, creatinine/eGFR, 25-OH vitamin D, urinary calcium.
   • Small visual: low PTH → ↓ calcium / ↑ phosphate.
3. Acute symptomatic hypocalcemia
   • Red-flag symptoms and IV calcium gluconate/ECG monitoring.
   • Correct magnesium and identify precipitant.
   • Transition to oral calcium + calcitriol.
   • Visual: urgent pathway with arrows.
4. Chronic conventional therapy
   • Oral calcium, activated vitamin D (calcitriol), nutritional vitamin D and magnesium as needed.
   • Individualize dose; advise calcium-rich diet; avoid excessive phosphate intake if hyperphosphatemic.
   • State target: symptom-free with low-normal calcium.
   • Visual: medication/food treatment cards.
5. Monitoring and complication prevention
   • Serum values + renal function + urinary calcium.
   • Hypercalciuria: reduce calcium burden where possible; low-sodium diet and thiazide consideration.
   • Renal imaging as indicated.
   • Visual: monitoring dashboard/renal protection diagram.
6. When to escalate: PTH replacement & take-home algorithm
   • Consider if conventional therapy inadequate or causes complications/high burden.
   • Endocrinology-led management.
   • Summarize “acute → conventional → monitor → escalate.”
   • Add brief references in footer or a compact reference box.

ARTIFACTS

• No .pptx file has been created yet.
• No local presentation files or images have been downloaded/saved yet.
• Generated image resource:
  • https://cdn.orris.care/image-gen/9a116f04e74345938543ef04df298543.png
• Clinical textbook resource accessed:
  • /textbooks/9780071837781/9780071837781_block21.md (relevant management doses and supplementation principles).
• PPTX creation instructions accessed:
  • /tmp/skills/pptx/SKILL.md
  • /tmp/skills/pptx/python-pptx.md

NEXT STEPS

1. Create a polished 16:9 six-slide .pptx with python-pptx.
2. Download/embed the generated infographic using the mandated helper script:
   • python /tmp/skills/shared/scripts/fetch_images.py "<image_url>"
3. Use native PowerPoint shapes/icons/diagrams for the remaining visual elements if no suitable external images are available.
4. Add concise evidence-based clinical content, avoid excessive detailed dosing or product-specific PTH claims, and include a sources footer/reference slide area.
5. Save the completed deck to an accessible output path and provide the user with a download link.

SESSION INTENT

SUMMARY

• User requested: “Principle of management of hypoparathyroidism — Ppt of 5-6 slides with appropriate images.”
• Medical-library and PPTX skills were invoked/read. The plan is to create a presentation from scratch using python-pptx, preferably 16:9 widescreen, with visual clinical infographic styling.
• Relevant evidence gathered:
  • Current guidance/search results (2025 European Journal of Endocrinology): conventional therapy for chronic hypoparathyroidism consists of adequate dietary calcium, with/without calcium supplements, plus activated vitamin D.
  • PTH replacement can reduce conventional-treatment pill burden and improve biochemical parameters/potentially quality of life; consider when conventional therapy cannot achieve satisfactory control.
  • Textbook evidence: calcitriol approximately 0.2–1 μg/day, elemental calcium supplementation 2–3 g/day, and magnesium supplementation when appropriate (these should be presented as common reference ranges, titrated individually—not rigid universal doses).
  • Main management targets: control symptoms, maintain serum calcium in low-normal or just-below-normal range, avoid hypercalciuria/hypercalcemia and hyperphosphatemia, preserve kidney function, and monitor complications.
  • Acute symptomatic/severe hypocalcemia: urgent IV calcium gluconate with ECG/cardiac monitoring, correct hypomagnesemia, then transition to oral calcium plus active vitamin D when stable. Specific IV dosing was not retrieved from sources, so if included, label as protocol-dependent and cite a standard guideline.
  • Chronic management: oral calcium (carbonate/citrate), active vitamin D (calcitriol/alfacalcidol), correct magnesium and native vitamin-D insufficiency, dietary measures (calcium adequate; avoid excessive phosphate), individualized treatment.
  • Monitoring: serum calcium (ionized or albumin-adjusted), phosphate, magnesium, creatinine/eGFR, 25-OH vitamin D; 24-hour urine calcium periodically; renal imaging if indicated. Reduce treatment-related renal risk; thiazide plus low-sodium diet may be used for persistent hypercalciuria, with monitoring.
  • PTH replacement is an escalation option for difficult-to-control disease, treatment intolerance/high pill burden, hypercalciuria/renal complications, poor quality of life, or excessive requirements. Availability/regulatory indications vary by country.
  • Post-thyroidectomy hypoparathyroidism may recover; monitor serial calcium/PTH, and permanent disease needs specialist/endocrinology follow-up.

1. Title: Principles of Management of Hypoparathyroidism
   Subtitle: Acute stabilization, chronic replacement & safe long-term monitoring.
2. Therapeutic goals & assessment: Low PTH → hypocalcemia, hyperphosphatemia, renal calcium loss; recognize symptoms; baseline labs and cause; goals including low-normal calcium and renal protection.
3. Acute symptomatic hypocalcemia: Emergency pathway—IV calcium gluconate, ECG monitoring, check/correct magnesium, treat triggers, oral regimen after stabilization.
4. Chronic conventional treatment: Oral calcium + active vitamin D as first line; adequate dietary calcium; magnesium/native vitamin D correction; dietary phosphate awareness.
5. Monitoring and prevention of complications: Serum and urine monitoring, renal safety, hypercalciuria management with low sodium ± thiazide, avoid overtreatment.
6. When to consider PTH replacement / take-home algorithm: Consider inadequate control or complications despite optimized conventional therapy; endocrine specialist care; concise “stabilize → replace → monitor → escalate” algorithm.

• Images:
  • Image search returned no usable results.
  • Two generated educational medical images are available and should be embedded if accessible:
    1. General hypoparathyroidism management infographic: https://cdn.orris.care/image-gen/9a116f04e74345938543ef04df298543.png
    2. Acute hypocalcemia emergency/IV calcium/ECG management infographic: https://cdn.orris.care/image-gen/629e281963644290bc283ce6fa0a59de.png
• External academic PDF/article extraction was attempted but failed; use the web-search result summaries rather than claiming direct quotations.
• No actual PPTX has yet been created.

ARTIFACTS

• Generated image resource (general management):
  • https://cdn.orris.care/image-gen/9a116f04e74345938543ef04df298543.png
• Generated image resource (acute emergency management):
  • https://cdn.orris.care/image-gen/629e281963644290bc283ce6fa0a59de.png
• Workspace inspected:
  • /tmp/workspace/attachments
• No presentation file or other user-facing output file has been created yet.

NEXT STEPS

1. Use python-pptx to create a polished 5–6 slide, 16:9 .pptx presentation in /tmp/workspace/.
2. Download/embed the generated images using the mandated helper:
   • python /tmp/skills/shared/scripts/fetch_images.py "<url>"
3. Build slides with concise bullets, an acute-vs-chronic visual distinction, and a final clinical algorithm.
4. Include a brief references footer or final small references section citing:
   • Second International Workshop guideline (2022),
   • 2025 EJE chronic hypoparathyroidism treatment guidance,
   • relevant textbook source.
5. Verify slide text/layout with python-pptx, render/inspect slides if available, then provide the output PPTX link/path to the user.